STAT5 Represses BCL6 Expression by Binding to a Regulatory Region Frequently Mutated in Lymphomas

Oncogene - United Kingdom
doi 10.1038/sj.onc.1209775
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BCL6 Represses Smad Signaling in Transforming Growth Factor- Resistance

Cancer Research
Cancer ResearchOncology
2008English

Identification of FUSE-binding Protein 1 as a Regulatory mRNA-binding Protein That Represses Nucleophosmin Translation

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

T(14;18)-Negative Follicular Lymphomas Are Associated With a High Frequency of BCL6 Rearrangement at the Alternative Breakpoint Region

Modern Pathology
Forensic MedicinePathology
2009English

Cis-Regulatory Somatic Mutations and Gene-Expression Alteration in B-Cell Lymphomas

Genome Biology
2015English

Interferon Regulatory Factor 2 Binding Protein 2 Is a New NFAT1 Partner and Represses Its Transcriptional Activity

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2011English

Novel BCL6 Inhibitor (FX1): Advances in Diffuse Large B-Cell Lymphomas (DLBCLs) Treatment

Biomedical Sciences
2017English

Memory B Cells Contribute to Rapid Bcl6 Expression by Memory Follicular Helper T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Long Noncoding RNA HOXA-AS2 Represses P21 and KLF2 Expression Transcription by Binding With EZH2, LSD1 in Colorectal Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

FBXO11 Targets BCL6 for Degradation and Is Inactivated in Diffuse Large B-Cell Lymphomas

Nature
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy